A VASP-Rac-Soluble Guanylyl Cyclase Pathway Controls cGMP Production in Adipocytes

被引:28
|
作者
Jennissen, Katja [1 ]
Siegel, Franziska [1 ]
Liebig-Gonglach, Michaela [1 ]
Hermann, Michaela-Rosemarie [1 ,2 ]
Kipschull, Stefanie [1 ]
van Dooren, Sander [1 ]
Kunz, Wolfram S. [3 ]
Faessler, Reinhard [2 ]
Pfeifer, Alexander [1 ,4 ]
机构
[1] Univ Bonn, Inst Pharmacol & Toxicol, D-53105 Bonn, Germany
[2] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany
[3] Univ Bonn, Div Neurochem, Dept Epileptol, D-53105 Bonn, Germany
[4] Univ Bonn, Pharma Ctr, D-53105 Bonn, Germany
关键词
STIMULATED PHOSPHOPROTEIN VASP; DEPENDENT PROTEIN-KINASE; BROWN ADIPOSE-TISSUE; ENA/VASP PROTEINS; NITRIC-OXIDE; MITOCHONDRIAL BIOGENESIS; ACTIN CYTOSKELETON; ENERGY-EXPENDITURE; SIGNALING PATHWAY; HUMAN-PLATELETS;
D O I
10.1126/scisignal.2002867
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitous second messenger cyclic guanosine monophosphate (cGMP) plays an important role in metabolism and promotes brown adipocyte differentiation. We showed that ablation of the gene encoding vasodilator-stimulated phosphoprotein (VASP), a major downstream component of the cGMP signaling cascade, increased cellular cGMP content in brown and white adipocytes and mouse embryonic fibroblasts. VASP-deficient cells showed increased activation of Rac1, which in turn increased the abundance of the cGMP-producing enzyme soluble guanylyl cyclase (sGC), the main receptor for nitric oxide. Consequently, loss of VASP caused increased cGMP concentrations and enhanced brown adipocyte differentiation. Consistent with the in vitro data, we found increased energy expenditure in VASP-deficient mice and exposure to cold triggered enhanced lipolysis and cellular respiration in VASP-deficient brown fat cells. In addition, VASP-deficient mice exhibited increased development of brown-like adipocytes in white fat. Our data revealed that a VASP to Rac to sGC negative feedback loop limited cGMP production, thereby regulating adipogenesis and energy homeostasis.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] ENHANCED GLOMERULAR CGMP AFTER STIMULATION OF SOLUBLE GUANYLYL CYCLASE (SGC) IN UNILATERAL URETERAL OBSTRUCTION (UUO)
    MCDOWELL, KA
    CHEVALIER, RL
    THORNHILL, BA
    NORLING, LL
    PEDIATRIC RESEARCH, 1994, 35 (04) : A369 - A369
  • [22] cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
    Moro, MA
    Russell, RJ
    Cellek, S
    Lizasoain, I
    Su, YC
    DarleyUsmar, VM
    Radomski, MW
    Moncada, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1480 - 1485
  • [23] Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target VASP in aorta
    Oelze, M
    Mulsch, A
    Mollnau, H
    Smolenski, A
    Walter, U
    Munzel, T
    CIRCULATION, 2000, 102 (18) : 351 - 351
  • [24] The soluble guanylyl cyclase stimulator BAY 41-2272 increases differentiation and function of brown adipocytes
    Jennifer Etzrodt
    Linda S Hoffmann
    Andreas Friebe
    Alexander Pfeifer
    BMC Pharmacology and Toxicology, 14 (Suppl 1)
  • [25] Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases
    Dupont, Lisa L.
    Glynos, Constantinos
    Bracke, Ken R.
    Brouckaert, Peter
    Brusselle, Guy G.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 29 (01) : 1 - 6
  • [26] Hypertension reduces expression of soluble guanylyl cyclase in the aorta via the Notch signaling pathway
    Rippe, Catarina
    Zhu, Baoyi
    Krawczyk, Katarzyna
    Van Bavel, Ed Van Bavel
    Albinsson, Sebastian
    Sjolund, Jonas
    Bakker, Erik N. T. P.
    Sward, Karl
    FASEB JOURNAL, 2017, 31
  • [27] Alterations in the nitric oxide / soluble guanylyl cyclase pathway enhance the risk of myocardial infarction
    de Wit, Cor
    Kaiser, Frank
    Aherrahrou, Zouhair
    Koesling, Doris
    Schunkert, Heribert
    Erdmann, Jeanette
    FASEB JOURNAL, 2013, 27
  • [28] Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-Independent but cAMP-dependent pathway
    Hwang, TL
    Hung, HW
    Kao, SH
    Teng, CM
    Wu, CC
    Cheng, SJS
    MOLECULAR PHARMACOLOGY, 2003, 64 (06) : 1419 - 1427
  • [29] Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells
    Browner, NC
    Dey, NB
    Boch, KD
    Lincoln, TM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (45) : 46631 - 46636
  • [30] Localization of the nitric oxide/cGMP signaling pathway-related genes and influences of morpholino knock-down of soluble guanylyl cyclase on medaka fish embryogenesis
    Yamamoto, T
    Yao, Y
    Harumi, T
    Suzuki, N
    ZOOLOGICAL SCIENCE, 2003, 20 (02) : 181 - 191